Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets

Japanese Journal of Pharmacology

Volumn 76, Issue 2, 1998, Pages 141-148

  Liao, Chang Hui ^a   Ko, Feng Ning ^a   Kuo, Sheng Chu ^b   Teng, Che Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 chloro 3 methoxycarbonylpropionamido 1,4 naphthoquinone (PP1D 1); Inositol 1,4,5 trisphosphate (IP3); Intracellular calcium concentration; Platelet (rabbit); Thapsigargin

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 CHLORO 3 METHOXYCARBONYLPROPIONAMIDO 1,4 NAPHTHOQUINONE; ADENOSINE TRIPHOSPHATE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; CALCIUM; COLLAGEN; CYCLIC GMP; IMIDAZOLE; INDOMETACIN; INOSITOL 1,4,5 TRISPHOSPHATE; PROSTAGLANDIN D2; PROSTAGLANDIN SYNTHASE; THAPSIGARGIN; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE B2; THROMBOXANE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; RABBIT; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 0031935901     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.76.141     Document Type: Article

References (28)

1. Genton M, Barnett HJM, Field WS, Gent M and Hoak JC: Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Stroke 8, 150-157 (1977)
2. Sherman DG and Hart RG: Thromboembolism and antithrombotic in cerebrovascular disease. J Am Coll Cardiol 8, 88B-97B (1986)
3. Trip MD, Cats VM, Capelle FJL and Vreeken J: Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 322, 1549-1554 (1990)
4. Genton E, Clagett GP and Salzman EW: Antithrombotic therapy in peripheral vascular disease. Chest 89, 75S-81S (1986)
5. Albers GW: Role of ticlopidine for prevention of stroke. Stroke 23, 912-916 (1992)
6. Karsten S: Antiplatelet drugs: a comparative review. Drugs 50, 7-28 (1996)
7. Anderson HV and Willerson JT: Thrombolysis in acute myocardial infarction. N Engl J Med 329, 703-709 (1993)
8. Teng CM, Ko FN and Yu SM: Inventory of exogenous factors affecting platelet aggregation isolated from plant sources. A report prepared on behalf of the Scientific and Standardization Committee's Registry of Exogenous Hemostatic Factors. Thromb Haemostas 71, 517-519 (1994)
9. Kuo SC, Toshire I, Huang LJ, Lien JC, Yean SR, Huang SC, Lednicer D, Susan MN and Lee KH: Synthesis and cytotoxicity of 1,2-disubstituted naphth[2,3-d]imidazole-4,9-diones and related compounds. J Am Chem Soc 39, 1447-1451 (1996)
10. Wang JP, Chen YH and Kuo SC: Inhibition of hind-paw edema and cutaneous vascular plasma extravasation by 2-chloro-3-methoxycarbonylpropionamido-1,4-naphthoquinone (PP1D1) in mice. Naunyn Schmiedebergs Arch Pharmacol 354, 779-784 (1996)
11. Teng CM, Chen WY, Ko WC and Ouyang C: Antiplatelet effect of butylidenephthalide. Biochim Biophys Acta 924, 375-382 (1987)
12. O'Brien JR: Platelet aggregation II. Some results from a new method of study. J Clin Pathol 15, 452-455 (1962)
13. DeLuca M and McElory WD: Purification and properties of firefly luciferase. Methods Enzymol 57, 3-15 (1978)
14. 2+ stores: studies using fura-2. Biochem Biophys Res Commun 139, 308-314 (1986)
15. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260, 3440-3450 (1985)
16. Dejana E, Villa S and De Gaetano G: Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemostas 48, 108-111 (1982)
17. 2+-independent activation for shape change and secretion. FEBS Lett 148, 21-26 (1982)
18. Handa RK, Dillingham EU and Gollamudi R: Antithrombotic nipecotamide increase cyclic AMP levels and inhibits protein phosphorylation in human platelets. Life Sci 57, 983-988 (1995)
19. Geiger J, Nolte C and Walter U: Regulation of calcium mobilization and entry in human platelets by endothelium-derived factors. Am J Physiol 267, C236-C244 (1994)
20. Siess W: Molecular mechanisms of platelet activation. Physiol Rev 69, 58-178 (1989)
21. Lapetina PG: Inositol phospholipids and GTP-binding proteins in signal transduction in stimulated human platelet. Adv Prostaglandin Thromboxane Leukot Res 16, 217-224 (1986)
22. Ishii GI, Connolly TM, Bross TE and Majerus PW: Inositol cyclic triphosphate [inositol 1,2-(cyclic)-4,5-triphosphate] is fromed upon thrombin stimulation of human platelets. Proc Natl Acad Sci USA 83, 6397-6401 (1986)
23. Vickers JD, Kinlough-Rathbone RL and Mustard JF: Changes in the platelet phosphoinositides during the first minute after stimulation of washed rabbit platelets with thrombin. Biochem J 219, 25-31 (1984)
24. Thastrup O, Foder B and Scharff O: The calcium mobilizing tumor promoting agent, thapsigargin elevates the platelet cytoplasmic free calcium concentration to a higher steady state level. A possible mechanism of action for the tumor promotion. Biochem Biophys Res Commun 142, 654-660 (1987)
25. 2+-ATPase. Proc Natl Acad Sci USA 87, 2466-2470 (1990)
26. 2+ elevation in rabbit platelets treated with thapsigargin. Biochem J 313, 83-89 (1996)
27. 2+ entry pathways activated by the tumor promotor thapsigargin in human platelets. Biochim Biophys Acta 1220, 37-41 (1993)
28. Brune B and Ullrich V: Cyclic nucleotides and intracellular calcium homeostasis in human platelets. Eur J Biochem 207, 607-613 (1992)